Table 2 Marginal bone loss (MBL), Primary and Secondary Implant Stability in Ostell ISQ values
Study | Year of publication | MBL at 6 months | MBL at 12 months | Primary stability. Ostell ISQ | Secondary stability. Ostell ISQ | Biologic complacations |
|---|---|---|---|---|---|---|
Eekeren et al. [16] | 2015 | not reported | 0.4 ± 0.5 | not reported | not reported | 1 |
Hasson et el. [17] | 2014 | not reported | 0.9 ± 0.5 | not reported | not reported | 0 |
Held et al. [18] | 2013 | 1.46 ± 0.7 | not reported | 43 ± 9 | 68 ± 10 | 2 |
Hicklin et.al. [19] | 2015 | 0.97 | not reported | 78 | 80 | 0 |
Hinkle et al. [20] | 2014 | 1.10 ± 0.58 | 0.99 ± 0.29 | not reported | not reported | 1 |
Le Gac et al. [21] | 2015 | not reported | not reported | not reported | not reported | 7 |
Liaje et al. [22] | 2013 | 0.14 ± 0.05 | 0.20 ± 0.40 | 78.39 ± 3.95 | 76.17 ± 4.45 | 0 |
Yu et al. [23] | 2016 | not reported | 0.35 ± 0.60 (24 months) | not reported | not reported | 0 |
Hadzik et al. [11] | 2017 | 0.53 ± 0.2 (3 months) | 0.57 ± 0.3 (9 months) | 66.5 ± 16.5 | 73.9 ± 8.4 | 0 |
Dard et al. [24] | 2016 | 0.53 ± 0.6 | 0.74 ± 0.68 | not reported | not reported | 0 |
Allen et al. [25] | 2016 | not reported | 0.81 24 months | 68.04 | 74.63 | 0 |
Al-Nawas et al. [26] | 2012 | 0.23 ± 0.37 | 0.32 ± 0.55 | not reported | not reported | 3 |
Calvo-Guirado et al. [27] | 2016 | 0.64 ± 0.38 | 0.71 ± 0.11 | 75.22 ± 1.23 | 78.33 ± 1.76 | 1 |
Ganeles et al. [28] | 2008 | not reported | 0.77 ± 0.93 | not reported | not reported | 10 |
Markovic et al. [29] | 2016 | not reported | not reported | 71.22 ± 6.05 | 67.68 ± 3.27 | 0 |
Morton et al. [30] | 2010 | 0.25 | 0.21 | not reported | not reported | 3 |
Nedir et al. [31] | 2013 | not reported | 0.5 ± 0.75 | not reported | not reported | 2 |
Nicolau et al. [32] | 2013 | 0.69 ± 0.80 | 0.76 | not reported | not reported | 11 |
Ryu et al. [33] | 2016 | not reported | 0.98 ± 88 | 76.34 ± 5.89 | 81.62 ± 2.00 | 0 |
Slotte et al. [34] | 2012 | not reported | 0.43 | not reported | not reported | 4 |